Filing Details
- Accession Number:
- 0000914190-12-000240
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-02 13:00:00
- Reporting Period:
- 2012-03-30
- Filing Date:
- 2012-04-02
- Accepted Time:
- 2012-04-02 15:21:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1133869 | Nile Therapeutics Inc. | NLTX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189164 | B Richard Brewer | C/O Nile Therapeutics, Inc. 4 West 4Th Avenue, Suite 400 San Mateo CA 94402 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-03-30 | 125,000 | $0.00 | 125,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (Right to Buy) | Acquisiton | 2012-03-30 | 93,750 | $0.00 | 93,750 | $0.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 93,750 | No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $0.32 | 2010-07-21 | 2020-07-21 | 450,000 | 450,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $0.37 | 2020-07-26 | 900,000 | 900,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-07-21 | 450,000 | 450,000 | Direct |
| 2020-07-26 | 900,000 | 900,000 | Direct |
Footnotes
- The reported securities were purchased by the Reporting Person at an aggregate price of $0.40 for one share of common stock and three-fourths of a warrant to purchase one share of common stock.
- This option vests in eight equal quarterly installments beginning 9/30/2011.
- The warrants are exercisable for a period of five years beginning on the earlier of (i) the date on which a registration statement under the Securities Act of 1933, as amended, covering the shares of common stock issuable upon exercise of the warrants and the subsequent resale of such shares is declared effective by the Securities and Exchange Commission, and (ii) one year and one day after issuance.
Billionaire Hedge Funds
